Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-03

Clinical Trial Update: Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a simulated post-exposure regimen for rabies has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Purified Vero Rabies Vaccine (Purified vero cell rabies vaccine)
  • Rabies Human Diploid Cell Vaccine (Rabies Human Diploid Cell Vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Rabies | Phase 2 | Status: COMPLETED